Influence of Dialysate Ca Concentrations on the Therapeutic Effects of Etelcalcetide with Concomitant Drugs in Patients with Secondary Hyperparathyroidism.

Secondary hyperparathyroidism (SHPT), a complication of haemodialysis, is commonly treated with calcimimetics. The impact of dialysates containing different calcium (Ca) concentrations on clinical efficacy of calcimimetics are unclear. We examined whether dialysate Ca concentrations influence the efficacy and dosing of etelcalcetide with concomitant drugs.